10x Insights
Loading account…
Companies / Healthcare / AEHR TEST SYSTEMS
AEHR

AEHR TEST SYSTEMS

HealthcareMedical Instruments
Ticker AEHRFREMONT, CAFiscal year ends DecemberBook value per share $7.16Diluted shares 30.7M

Aehr Test Systems, Inc. (NASDAQ: AEHR) is a leading provider of test solutions for semiconductor devices, headquartered in Fremont, California. The company's website is www.aehr.com. From the company’s description.

Fiscal year 2023 · ends 12-31Changes are against fiscal 2022The amber dot is the latest twelve months, to 2026-05-29
Sales & profitability
$64.96M
+27.8% year over year
Last 12 mo $55.99M
20.59%
+5.2 percentage points
Last 12 mo 8.76%
$14.56M
+54.0% year over year
Last 12 mo $11.34M
19.26%
+0.7 percentage points
Last 12 mo 5.17%
Cash & financing
$10.01M
+563.9% year over year
Last 12 mo $14.10M
$8.65M
+692.0% year over year
Last 12 mo $12.54M
—
Was 0.00× a year earlier
29.2M
+5.2% year over year
Last 12 mo 30.7M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What AEHR TEST SYSTEMS does

In the company’s own words

Aehr Test Systems, Inc. (NASDAQ: AEHR) is a leading provider of test solutions for semiconductor devices, headquartered in Fremont, California. The company's website is www.aehr.com.

Aehr Test designs, manufactures, and markets advanced test and burn-in systems that screen semiconductor devices for defects and reliability across wafer level, singulated die, and package level applications. The company serves semiconductor manufacturers, contract assemblers, electronics manufacturers, and independent test and burn-in service companies worldwide.

The company operates through two primary product categories. Wafer level and die level test and burn-in systems, which accounted for 63 percent of fiscal 2026 revenues, include the FOX-XP, FOX-NP, and FOX-CP platforms designed for testing entire wafers or singulated die and modules. These systems incorporate proprietary WaferPak Contactors, DiePak Carriers, WaferPak Aligners, and DiePak Loaders that enable high-throughput, cost-effective testing. Package level test and burn-in systems, representing 37 percent of fiscal 2026 revenues, comprise the Sonoma series for ultra-high-power applications, the Tahoe series for medium-power reliability testing, and the Echo series for low-power applications.

Aehr Test's solutions address mission-critical applications including artificial intelligence processors, silicon carbide and gallium nitride power semiconductors for electric vehicles, silicon photonics for data centers, automotive sensors, and memory devices. The company holds 125 active patents with expiration dates ranging from 2028 to 2045.

As of May 29, 2026, Aehr Test employed 138 regular full-time employees across principal offices in the United States, Germany, Taiwan, and the Philippines, with additional service personnel located at customer facilities worldwide. The company maintains a concentrated customer base, with five largest customers accounting for approximately 70 percent of fiscal 2026 net revenues. Fiscal 2026 net revenues totaled approximately $50 million, with backlog of $80.6 million as of May 29, 2026.

Company details
Sector
Healthcare
Industry
Medical Instruments
Headquarters
FREMONT, CA
Fiscal year end
December
CIK
1040470
SIC
3825

Financial performance, year by year

Fiscal 2012–2023 · USD
$-13.96M$7.56M$29.09M$50.61M$72.14M201220132014201520162017201820192020202120222023Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns AEHR TEST SYSTEMS — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

188
funds hold it
1 of 35
superinvestors hold it
$704.24M
held by funds, at market
23.0%
of shares held by funds

Superinvestors in AEHR TEST SYSTEMS · what they did last quarter

Polen CapitalDECREASED -16.7%
Polen Capital Management
0.1%of 13F portfolio

Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.

Largest fund holders · AEHR TEST SYSTEMS’s weight in each

VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
iShares Russell 2000 ETF
IWM · iShares Trust
0.09%of fund net assets
0.04%of fund net assets
Fidelity Small Cap Growth Fund
FCPGX · Fidelity Securities Fund
0.72%of fund net assets
VANGUARD EXTENDED MARKET INDEX FUND
VXF · VANGUARD INDEX FUNDS
0.03%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do AEHR TEST SYSTEMS and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of AEHR TEST SYSTEMS's earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in AEHR TEST SYSTEMS's last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.